Excitatory and inhibitory mechanisms in Wilson's disease: Investigation with magnetic motor cortex stimulation

Journal of the Neurological Sciences

Volumn 192, Issue 1-2, 2001, Pages 35-40

  Perretti, Anna ^a   Pellecchia, Maria Teresa ^a   Lanzillo, Bernardo ^b   Campanella, Giuseppe ^a   Santoro, Lucio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b IRCCS   (Italy)

Author keywords

Transcranial magnetic electric cortical stimulation; Wilson's disease

Indexed keywords

PENICILLAMINE; ZINC SULFATE;

ABDUCTOR POLLICIS BREVIS MUSCLE; ADULT; ARTICLE; CEREBELLUM; CLINICAL ARTICLE; CLINICAL FEATURE; ELECTROSTIMULATION; EVOKED MUSCLE RESPONSE; EXTRAPYRAMIDAL SYMPTOM; EXTRAPYRAMIDAL SYSTEM; FEMALE; HUMAN; MALE; MOTOR CORTEX; MOTOR DYSFUNCTION; MOTOR NERVE CONDUCTION; MOTOR PERFORMANCE; NERVE CELL EXCITABILITY; NERVE CELL INHIBITION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PYRAMIDAL TRACT; SCORING SYSTEM; SKELETAL MUSCLE; THUMB; TIBIALIS ANTERIOR MUSCLE; TRANSCRANIAL MAGNETIC STIMULATION; WILSON DISEASE;

ADULT; ELECTRIC STIMULATION; EVOKED POTENTIALS, MOTOR; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; MAGNETICS; MALE; MIDDLE AGED; MOTOR CORTEX; MOVEMENT; MUSCLE CONTRACTION; MUSCLE, SKELETAL; NEURAL CONDUCTION; NEURAL INHIBITION; NEURAL PATHWAYS; REACTION TIME;

EID: 0035889613     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(01)00594-9     Document Type: Article

References (26)

1. Wilson's disease
2. Wilson's disease: MRI with clinical correlation
3. Nutritional and metabolic disorders
4. Abnormal conduction in corticospinal pathways in Wilson's disease: investigation of nine cases with magnetic brain stimulation
5. Motor impairment in Wilson's disease 3: the clinical impact of pyramidal tract involvement
6. Spinal motor neuron excitability during the silent period after cortical stimulation
7. Magnetic brain stimulation: the silent period after the motor evoked potential
8. Quantitative evaluation of the silent period, evoked by transcranial magnetic stimulation during sustained muscle contraction, in normal man and in patients with stroke
9. Motor inhibition and excitation are independent effects of magnetic cortical stimulation
10. Inhibitory period following motor potentials evoked by magnetic cortical stimulation
11. Silent period evoked by transcranial stimulation of the human cortex and cervicomedullary junction
12. On the origin of the postexcitatory inhibition seen after trancranial magnetic brain stimulation in awake human subjects
13. Spinal and supraspinal mechanisms contribute to the silent period in the contracting soleus muscle after transcranial magnetic stimulation of human motor cortex
14. Parkinson's disease rigidity: magnetic motor evoked potentials in a small hand muscle
15. Postexcitatory inhibition in Huntington's disease
16. Motor cortical inhibition and the dopaminergic system: pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism
17. Electromyographic silent period after transcranial brain stimulation in Huntington's disease
18. Transection of the oesophagus for bleeding oesophageal varices
19. Hepatotoxische Storungen und Leberzerfallkskoma
20. Non invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee
21. Motor evoked potentials in Wilson's disease: early and late motor responses
22. Involvement of cortico-spinal tract in Wilson's disease: a study of three cases with transcranial stimulation
23. Electric and magnetic stimulation of human motor cortex: surface EMG and single unit responses
24. Single- and multiple-unit analysis of cortical stage of pyramidal activation
25. Effects of voluntary contraction on descending volleys evoked by transcranial stimulation in conscious humans
26. SPECT imaging of dopamine D2 receptors with 1231-IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's disease